Most people think about aging in terms of what they can see: wrinkles, weight changes, performance decline. What is actually happening at the cellular level is often a decline in energy production. Mitochondria, the organelles responsible for generating ATP, become less efficient over time. Oxidative stress damages the inner mitochondrial membrane, and cardiolipin, a specialized phospholipid that forms the structural foundation of that membrane and anchors the electron transport chain proteins, deteriorates. As cardiolipin deteriorates, the entire energy production process becomes less efficient. SS-31 is a peptide studied for its ability to concentrate at that exact site and act as a targeted antioxidant, and at AgeRejuvenation it is offered only under clinical supervision.
SS-31 is one of the more mechanism-specific peptides studied in longevity medicine, and it works at a level most aging conversations never reach: the inner mitochondrial membrane, where cells actually make energy. This guide explains what SS-31 is, how it interacts with cardiolipin, what it may support, who is a candidate, how it is administered, the safety considerations, and how it compares to other antioxidants. At AgeRejuvenation, SS-31 is offered only as part of our advanced supervised peptide therapy program, individually evaluated and clinically monitored.
What Is SS-31 Peptide?
Answer: SS-31, also known as elamipretide, is a tetrapeptide that accumulates selectively in the inner mitochondrial membrane, where it binds to cardiolipin and acts as a targeted antioxidant rather than working broadly throughout the cell.
Unlike a general supplement, SS-31 is designed to concentrate precisely where mitochondrial dysfunction originates. Mitochondria are the structures that generate ATP, the molecule cells use for nearly every energy-requiring process, and the National Library of Medicine describes the role mitochondria play as the cell's energy producers. SS-31 is the research designation for the same compound studied as elamipretide, so the two names refer to one tetrapeptide.
How Does SS-31 Work?
Answer: SS-31 binds to cardiolipin in the inner mitochondrial membrane, a phospholipid that anchors the electron transport chain, and may help stabilize that membrane while reducing the oxidative stress that degrades it.
The electron transport chain relies on cardiolipin to hold its protein complexes in place so electrons flow efficiently and ATP is produced. When cardiolipin is oxidized or degraded, those complexes separate, electron flow becomes less efficient, and reactive oxygen species accumulate, a cycle the National Institutes of Health reviews in its work on how mitochondrial dysfunction contributes to aging. SS-31 is studied for its ability to interrupt that cycle at the source by binding cardiolipin directly.
What May SS-31 Support?
Answer: SS-31 is studied for its potential to support mitochondrial efficiency, cellular energy production, and antioxidant protection of the inner mitochondrial membrane, which connects to fatigue, recovery, and metabolic and cardiac tissue that depend heavily on ATP.
Because mitochondrial decline sits upstream of many age-related changes, the potential effects are framed as support rather than cure. When mitochondria produce less ATP, persistent low energy is often the most noticeable result, a connection relevant to patients managing chronic fatigue and low energy conditions. The heart is among the most mitochondria-dense tissues in the body because it requires continuous ATP, which is why cardiac mitochondria are a recognized focus of SS-31 research. These are areas of active study, and individual benefit is not guaranteed.
Who Is a Candidate for SS-31?
Answer: SS-31 may be appropriate for adults focused on cellular aging, persistent fatigue, or mitochondrial health, but candidacy is determined only after a clinical evaluation of your full health picture and current medications.
SS-31 is not appropriate for everyone, and it is not a first-line therapy. Our clinical team reviews cardiovascular status, metabolic markers, medication list, and goals before recommending it. People who are pregnant or breastfeeding, or who have significant untreated medical conditions, are generally not candidates. The evaluation step is required, not optional, because the right protocol depends on your actual biology.
How Is SS-31 Administered?
Answer: SS-31 is typically delivered as a subcutaneous injection on an individualized schedule, with protocol duration and frequency set by your provider rather than a fixed regimen.
We do not publish a one-size dose, because appropriate dosing depends on your evaluation and goals. SS-31 is a compounded prescription peptide, so it is prepared and supervised through a clinical relationship rather than purchased and self-administered. Many patients are evaluated for whether SS-31 fits within a broader longevity stack alongside other peptides, which is reviewed for safety at the consultation.
SS-31 vs. General Antioxidants
Answer: General antioxidants such as CoQ10 and vitamin C act broadly across the cell, while SS-31 is designed to concentrate in the inner mitochondrial membrane, the precise site where mitochondrial dysfunction begins.
| Property | SS-31 (elamipretide) | General antioxidants (CoQ10, vitamin C) |
|---|---|---|
| Primary site of action | Inner mitochondrial membrane | Throughout the cell, less site-specific |
| Mechanism | Binds cardiolipin, supports the electron transport chain | Broad free-radical scavenging |
| Delivery | Compounded prescription peptide, usually subcutaneous | Oral supplements |
| Supervision | Clinical evaluation and monitoring required | Generally available over the counter |
The distinction is selectivity. By targeting the membrane where energy production actually fails, SS-31 is studied for higher local concentrations at that site than a systemic antioxidant typically reaches. The two approaches are not interchangeable, and SS-31 is used as a clinical tool, not a substitute for a balanced antioxidant intake.
What Are the Side Effects and Safety Considerations?
Answer: Because SS-31 is an advanced and less-studied peptide, it is used only under clinical supervision, and any new or unexpected symptoms during a protocol should be reported to your provider promptly.
We do not overstate what is known. SS-31 is a compounded prescription peptide, and the long-term safety profile continues to be studied, which is exactly why evaluation, monitoring, and an open line to your clinical team are built into care here. Self-sourcing peptides outside a supervised program carries real risks around purity, dosing, and interactions, and we strongly advise against it.
What Should I Expect From an SS-31 Protocol?
Answer: Expect a longevity-focused consultation, an individualized plan, and gradual rather than immediate changes, since mitochondrial health responds over weeks to months rather than overnight.
The process begins with a 45 to 90 minute consultation that reviews your history, goals, and relevant markers. If SS-31 is appropriate, your provider sets the protocol and follow-up cadence. Some patients report improved energy and recovery over a period of weeks, while broader cellular effects are evaluated over months, and your response is reassessed rather than assumed.
Why Choose AgeRejuvenation for SS-31?
Answer: SS-31 is an advanced longevity peptide that calls for a provider who understands its mechanism and how it fits a complete protocol, which a rushed visit cannot provide.
Our clinical direction is led by Dr. Dawn Ericsson, MD, and our team builds longevity programs that address aging at multiple levels rather than relying on a single compound. SS-31 is one tool, evaluated against your actual biology, within our physician-led peptide therapy program and our broader advanced longevity peptide hub. The same principle applies throughout our longevity peptide therapy program: protocols grounded in clinical evaluation, supervised from start to finish, never guesswork.
Explore more in our wellness center services .
